- Home
- CRL vs PFSI Comparison
CRL vs PFSI Comparison
Compare CRL & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRL | PFSI |
|---|---|---|
| Founded | 1947 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 7.9B |
| IPO Year | 2000 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CRL | PFSI |
|---|---|---|
| Price | $215.43 | $148.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $205.27 | $151.13 |
| AVG Volume (30 Days) | ★ 664.0K | 383.6K |
| Earning Date | 02-18-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 0.80% |
| EPS Growth | N/A | ★ 191.00 |
| EPS | N/A | ★ 9.30 |
| Revenue | ★ $4,023,704,000.00 | $2,723,457,000.00 |
| Revenue This Year | N/A | $8.09 |
| Revenue Next Year | $1.70 | $26.48 |
| P/E Ratio | ★ N/A | $16.07 |
| Revenue Growth | N/A | ★ 21.25 |
| 52 Week Low | $91.86 | $85.74 |
| 52 Week High | $228.88 | $160.36 |
Technical Indicators
Market Signals| Indicator | CRL | PFSI |
|---|---|---|
| Relative Strength Index (RSI) | 53.76 | 59.21 |
| Support Level | $217.57 | $146.00 |
| Resistance Level | $224.78 | $153.16 |
| Average True Range (ATR) | 7.35 | 5.00 |
| MACD | -1.33 | -0.11 |
| Stochastic Oscillator | 32.29 | 55.01 |
Price Performance
Historical ComparisonAbout CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
About PFSI PennyMac Financial Services Inc.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.